John M. Leonard
2017 - Intellia Therapeutics
In 2017, John M. Leonard earned a total compensation of $2.6M as President and Chief Executive Officer former Executive Vice President, Research & Development at Intellia Therapeutics, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $156,170 |
|---|---|
| Option Awards | $2,024,297 |
| Salary | $395,833 |
| Other | $16,574 |
| Total | $2,592,874 |
Leonard received $2M in option awards, accounting for 78% of the total pay in 2017.
Leonard also received $156.2K in bonus, $395.8K in salary and $16.6K in other compensation.
Rankings
In 2017, John M. Leonard's compensation ranked 4,285th out of 14,666 executives tracked by ExecPay. In other words, Leonard earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,285 out of 14,666 | 71st |
Division Manufacturing | 1,503 out of 5,768 | 74th |
Major group Chemicals And Allied Products | 430 out of 2,074 | 79th |
Industry group Drugs | 330 out of 1,730 | 81st |
Industry In Vitro and In Vivo Diagnostic Substances | 7 out of 72 | 90th |
Source: SEC filing on April 17, 2018.
Leonard's colleagues
We found three more compensation records of executives who worked with John M. Leonard at Intellia Therapeutics in 2017.